The College points to data gathered from its 2024 VN Vision workshops which showed that many nurses believe their skills and capabilities, and the scope of tasks that can be performed within the current legal framework, are not being fully used.
This new project aims to gather insights and empower nurses to play a more central role in the sector by promoting greater involvement in:
Session dates, times and locations are as follows:
Julie Dugmore RVN, RCVS Director of Veterinary Nursing, said: “Informed by conversations with professionals across the sector and a deep understanding of current practice, this new project recognises that achieving meaningful change requires a fundamental cultural shift.
"Clear guidance, structured support and open dialogue will be key in empowering veterinary teams to adapt to a new way of working.
“An additional crucial focus will be on enhancing public understanding of the Registered Veterinary Nurse (RVN) role, alongside support for developing stronger interprofessional and public-facing communication.”
Jill Macdonald RVN, VN Futures Lead, added: “These interactive sessions will play an important role in this new branch of VN Vision work, helping to define long term goals, identify the practical steps needed to achieve them, and determine how success will be measured and shared with the wider public.
“We were honoured to have so many fantastic nurses come together last year to help shape the future of the profession, and we’re looking forward to many more engaging conversations with vet team members this time around.
"This is more than just a conversation though – it’s a national effort to strengthen the RVN role through collaboration, clarity and confidence.”
The ‘A vision or a necessity: strengthening the role of veterinary nurses in team-based veterinary healthcare’ workshops are open to all practice team members, including, but not limited to, veterinary nurses, veterinary surgeons, practice support staff, directors, managers, and practice owners.
Workshops will be informal, informative and made up of small groups.
Supper will also be provided.
https://www.eventbrite.com/cc/vet-nursing-vision-events-3253639
https://www.rcvs.org.uk/news-and-views/publications/vn-vision-the-future-of-team-based-veterinary-healthcare/
Rowe Referrals, part of IVC Evidensia Referrals, was one of the very first practices to have an onsite MRI when it installed a 1.5T model five years ago. Now, thanks to investment from IVC Evidensia - of which it is a part - Rowe has been able to replace the ageing model with a new 3.0T machine, which will enable clinicians to diagnose and implement treatment plans quicker.
Referrals Manager at Rowe Referrals, Meg Hayman, said: "The difference between the two machines in amazing. The 1.5T produced very detailed scans but the 3.0T is incredible! It gives our clinicians the ability to perform more complex investigations with far greater clarity.
The practice says benefits will be seen across all disciplines, including neurology, internal medicine, ophthalmology, dentistry, orthopaedics and soft tissue.
Ian Jennings BSc BVSc CertVDI MRCVS RCVS Advanced Practitioner in Diagnostic Imaging said: "The new 3.0T MRI scanner allows us a much more detailed view of our patients, and has been especially useful for detection of smaller lesions in our neurological and orthopaedic cases. Specialised sequences can also be performed in less time, allowing us a greater ability to help more patients."
The procedure has already been performed in the US and Germany, where it is reported to have had a success rate of 70-80% in around 250 cases, many of which were show jumpers, eventers and dressage horses.
The team at Liphook, led by European Specialist Rachel Tucker (pictured), has now performed the procedure on six horses.
Rachel said: “Enlargement of the articular process joints of the lower neck is a relatively common finding in horses, but occasionally this can cause compression and irritation of the spinal nerves.
"The foraminotomy procedure means horses experiencing nerve pain can be made comfortable and have a good chance of returning to ridden work and a competition career.
“The surgery is minimally invasive but it is a very delicate procedure to perform because you are working very close to the spinal cord.
"Due to the location, the surgery is performed down a single portal under direct visualisation using a camera, guided by ultrasound and X-ray.
"What has been remarkable so far has been the rapid recovery of the horses, who have been home and out in a small paddock within a few days of surgery with some showing rapid signs of improved comfort and movement.
“We are very pleased with how the procedures at Liphook went.
"Our patients are continuing to recover well and we are looking forward to following their progress in the future.
The BSAVA says there unique opportunities and risks to the use of antibiotics in rabbits.
For example, antibiotic combination therapy, which is discouraged in dogs and cats, can be safe and effective in this species.
Also, careful selection of appropriate antibiotics, in terms of active substance, dose and route of administration, is crucial when treating rabbits due to the risk of enterotoxaemia.The new guide gives advice on diagnosing bacterial infections, likely causal organisms and appropriate antibiotic and non-antibiotic management.
The guide covers dacryocystitis, ear disease, facial abscesses, enteritis, urinary tract disease, and upper and lower respiratory tract disease.John Chitty, one of the authors, said: “Choosing an antibiotic for rabbits is not simple.
"Their diseases do not necessarily mirror those of dogs and cats, and they do have gut sensitivities to certain antimicrobials.
"However, like dogs and cats, there are situations where antibiotics are not needed where we once thought they were.
"This is especially important in reducing antibiotic usage in rabbits and, of course, in reducing use of critically important antibiotics in them as well.
"We hope this guide will help practitioners to see when antibiosis is needed, what choices are available and how to sample and select the most appropriate drug if needed.”The new guide is free to all and can be accessed at bsavalibrary.com/protectme.
The patient was a four-year-old Labrador called Vinny who, in 2019, became the first dog in the UK to receive a BioMedtrix canine ankle replacement system, implanted by Wear's Head of Orthopaedic Surgery, RCVS Specialist Neil Burton, assisted by Maciej Krukowski.
That first surgery, on Vinny’s right ankle, was successful. However, two years later he needed similar treatment to his left leg.
Neil said: “Vinny first presented to us at Wear Referrals in 2019 with hind limb lameness.
“He was diagnosed with osteoarthritis in his hock joints bilaterally due to a developmental condition called osteochondrosis of the talus causing him ongoing pain and lameness. We operated on the right ankle, with Vinny becoming the first dog in the UK to have this ankle replacement system placed.
“Vinny was significantly more comfortable on this limb postoperatively but his lameness progressively worsened in the left hind limb. The decision was made to perform the same surgery on the left ankle, making Vinny the first dog in the world to have this surgery performed bilaterally.
“Vinny has made another fine recovery from surgery and is now off medication, meaning he can exercise unrestricted and pain-free without a lifetime reliance on painkilling drugs.
“For our team at Wear to be able to offer him this pioneering surgery has been a great opportunity. He’s now a unique case, being both the first UK recipient of this BioMedtrix joint replacement as well as the world's first bilateral ankle replacement with the same system.”
For more information, visit www.wear-referrals.co.uk.
Conducted as a multicentric international study involving board-certified veterinary dermatologists, the trial included 35 dogs with CIF in at least two paws.
Each dog acted as its own control, and was treated with systemic antibiotics, with one paw being treated with FLE and the other paw without.
Paws were allocated based on a coin toss, and the study was single blinded: the principal investigator was responsible for the assessment of lesions, and the co-investigator was responsible for administration of FLE treatment.
The dogs were assessed over an 8-week period with check-ups every 14 days.
At every check-up the paws treated with FLE showed a greater improvement than paws without FLE treatment.
The lesions were assessed and scored with the global lesion score, the pruritic visual analogue scale, a cytological scoring, and photographic documentation.
The results of the study demonstrated that FLE combined with systemic antibiotics significantly reduced the time to clinical resolution compared to antibiotics alone.
By week four, 50% of paws in the FLE group had reached clinical resolution compared to 17% in the control group.
By week eight, 88% of paws in the FLE group had healed compared to 54% in the control group.
Dr Anja Lange, DVM, Department of Dermatology, AniCura Kleintierspezialisten Augsburg GmbH, Augsburg, Germany, said: “Canine interdigital furunculosis is a challenging condition to treat that can be prolonged and frustrating.
"Having FLE as an additional management tool is very exciting, not least because it speeds up time to healing, but it also requires us to use less antibiotics.
"The use of FLE was well accepted by all of the dog owners from the study and the dogs themselves tolerated it well, showing it can be a very useful adjunct to cases in clinical practice.”
Reference
Nutramega contains omega-3 fatty acids, specifically EPA and DHA, which the company says are critical for the overall health of animals, with many health benefits, including joints & mobility, skin & coat, heart health, the kidneys and brain health.
Nutramega comes in two sizes, 100ml and 200ml, with prices starting from £20.00.
Pet Ready LifeStages are health chews designed to provide daily support for puppies, adult dogs and senior dogs.
Each LifeStage product comes in 30 and 90 chew packets and prices range from £19.99 to £34.99.
www.nutravet.co.u
Virbac says this is the only wet product to provide separate species-specific dog and cat convalescence diets tailored to the unique nutritional needs of both species.
In an internal study conduct by Virbac, 86% of dogs with digestive issues improved within a week of using the diet1
The new diets are high in protein and low in carbohydrate and they can be used alone or in combination with the company's dry diets (suggested 50/50 split).
Andrew Connolly, Marketing Director – UK & Ireland at Virbac said: “We’re thrilled with the overwhelmingly positive feedback we've received on our new Veterinary HPM Digestive Support wet diets.
“Practices and pet owners alike are commenting on the extraordinary palatability of the diets and their effectiveness, particularly with convalescing and inappetent pets”.
The company now expects the vaccine will not be available until June 2025.
The company apologised for the disruption and inconvenience and says it will provide more information as soon as it becomes available.
For further information contact your Zoetis Account Manager or call Head Office on 0345 300 8034.
At the meeting, Simon Biles from Moore Scarrott gave a 30 minute presentation, which was followed by a one hour discussion.
The recording can be watched on VetNurse.co.uk here https://www.vetnurse.co.uk/001/nonclinical/m/meetings/156693, where you can also claim the time watching towards your annual CPD requirement. Press the 'Claim CPD' red button in the title bar towards the top.
To make it easier to find content that interests you, there are markers on the video timeline.
There is also a forum thread on vetsurgeon.org for further discussion of any of the points raised in the film. See: https://www.vetnurse.co.uk/001/nonclinical/f/vetnurse-site-support/32174/vetnurse-zoom-ir35-locums-umbrella-companies-and-corporates/177103#177103
For more information about Moore Scarrott, visit: https://www.moore-scarrott.co.uk
The report comes on the back of a survey by the association which found that 93% of vets say sustainability is important to them.
The BVA says the report aims to break down the challenge that both teams and individuals face in working towards net zero emissions.
It explains the impact of climate change, what the veterinary profession’s role is in tackling it and why the BVA thinks it is so important that the profession plays its part.
The report also includes resources and showcases the ways real veterinary workplaces are taking action to reduce their impact on the environment.
British Veterinary Association Senior Vice President Anna Judson said: “Many veterinary professionals have long been concerned about the impact the sector is having on the environment, and many are already taking action to mitigate this.
"However, there is still more work to do.
"Our vision is that by 2050 the profession will have adapted to support the UK’s net zero targets; is trusted on mitigating its own carbon footprint; and is a leading advocate for environmental sustainability.
"This new report is providing vet teams with the tools and the inspiration to do their bit, because small changes add-up to make a big difference.”
There'll be a session on the subject at the London Vet Show this year, chaired by Anna Judson, with panelists Ed Bailey, Clinical Director and Sustainability Lead at George Farm Vets, Laura Binnie, Sustainability Lead at Paragon Veterinary Group and James Bevan, Planetary Health Senior Teaching Fellow Public Health Registrar, University of Southampton.
"Practice what you preach: Reaching net zero is a team effort" will be held at 10.45am - 11.45am on 14 November in the BVA Congress Theatre.
www.bva.co.uk/net-zero-report
The update includes a new scoring system of low, moderate or high cancer risk which replaces the original numerical HDI scores and simplifies interpretation for clinicians, making the screening process easier to communicate with pet owners.
HT Vista says the device can now categorise cancer risk levels, based on malignant probability, with a sensitivity of 90% and a negative predictive value (NPV) of 98%.
The company says this translates to a “low cancer risk” result having a malignant probability of 10% or less, allowing veterinary teams to rule out cancer of lumps and bumps without the need for invasive procedures.
The tool can also now provide alerts for some of the low-risk cases, identifying them as lipomas, sebaceus adenomas or benign epithelial masses.
Liron Levy-Hirsch DVM MRCVS, Managing Director at HT Vista, said: "I am incredibly excited to enhance our already powerful HT Vista screening tool with a new diagnostic capability, providing veterinary teams with an even more comprehensive decision-support system.
"Our screening technology has already been a game-changer in early detection, and now, with the ability to flag specific tumour types, we are taking another significant step forward.
"This advancement empowers veterinary professionals to make even more informed decisions, supports shared decision-making with pet owners, and ultimately improves patient outcomes.
"By reducing the time from suspicion to diagnosis and treatment, we can detect cancer earlier, avoid the ‘wait and see’ approach, and help save more lives."
On the other end of the scale, a “high cancer risk” result has a malignant probability of 50% or more and indicates a stronger likelihood of malignancy.
HT Vista says these cases require additional diagnostic tests for mass identification.
The company highlights a big distinction between this and other screening modalities is that it can be nurse-led.
HT Vista will be on display and there will be live demonstrations at BSAVA Congress from the 20th to the 22nd of March 2025.
https://bit.ly/ht-vista-screening-tool
The panel will present the latest information on the prevalence of this zoonotic disease, review prevention strategies, and highlight the significance of cystic echinococcosis in humans.
The panelists are:
Dr Carolyn Kyte MRCVS (pictured), Elanco's UK Technical Consultant said: “We are concerned about potential changes in the distribution of Echinococcus granulosus in the UK and a subsequent change in zoonotic risk.
"We are hoping this cross-disciplinary discussion will provide Congress and Expo attendees with the latest insights the profession needs to allow individual, risk-based parasite control in dogs.
"The responsible use of parasiticides needs a true One-Health collaborative approach.”
Winners of the 2008 Petplan Veterinary Awards, which recognise and applaud staff and practices for their outstanding excellence and service, will feature on Natasha Kaplinsky's Channel Five news slot from tonight at 5:00pm, and then again at 7:00pm.
Tonight's news will cover the story of the Veterinary Practice of the Year: Orwell Veterinary Group, and there'll be more coverage on Tuesday and Wednesday as follows:
Tuesday 13th May 5pm & 7pm - Vet of the Year - Brian Faulkner of the Melton Veterinary Surgery
Wednesday 14th May 5pm & 7pm - Vet Nurse of the Year - Louisa Baker of the Priors Leaze Veterinary Centre.
Should be great publicity for the profession, and it is difficult to achieve this sort of thing, so hats off to Petplan.
The new oncology department has a dedicated chemotherapy room, access to a variety of chemotherapy drugs and a fully equipped operating theatre – offering soft tissue and orthopaedic surgery services for surgical oncology cases.
The department also has access to high frequency ocular ultrasound, magnetic resonance (MRI), and computed tomography (CT) scan equipment.
The service will be led by residency-trained clinician in Small Animal Oncology, Nina Vigevani DVM MRCVS.
She graduated in 2019 from the University of Milan, completed a rotating internship and worked in general practice in Milan, before moving to the UK to start on an oncology internship at a referral practice in the South of England.
Prior to moving to Chestergates, she completed her Residency in Small Animal Oncology at the University of Liverpool.
https://chestergates.org.uk/referral-services.
This allows patients to try the drug at lower cost, before progressing to the 30ml bottle for ongoing treatment.
Samantha Taylor, RCVS Recognised Specialist in Feline Medicine said: “It’s great we now have the option to prescribe the smaller 12ML bottle for starting cats on Senvelgo, as it means we don’t have to worry about wasting a 30ml bottle if it becomes evident that the cat requires insulin in the first couple of weeks.”
https://senvelgo.co.uk
The new RVN Council members are: Emily Bacon RVN, Macauly Gatenby RVN, Dan Lidgbird RVN and Krishna Mistry RVN, with Alice Langstone taking the student seat.
The incoming BVNA officer team for the 2025/6 term is (pictured left to right): Sarah Holliday RVN – President, Lyndsay Hughes RVN – Senior Vice President, Steph Worsley RVN – Junior Vice President, Nikki McLeod RVN – Honorary Secretary, Hamish Morrin RVN – Honorary Treasurer.
The webinar is the first of several events which will focus attention on patients owned by the estimated 80% of owners who feel that their pets with canine osteoarthritis (OA) may be suffering from off-days that can be associated with breakthrough pain¹.
During the session, Matt will explain the impact breakthrough pain has on the pet and owner and how to approach it more effectively using analgesic and rehabilitation tools and strategies.
James Beaumont, Marketing Manager at Animalcare, said: “Veterinary surgeons have told us that they estimate that nearly half of their canine OA cases on daily NSAIDs experience breakthrough pain.²
"Additionally, a proportion of pet owners state their dogs experience off-days and believe their pet suffers as a result of the condition³."
Animalcare says that some of the main factors in osteoarthritis breakthrough pain can include variable plasma drug levels between doses, intermittent treatment protocols or poor owner adherence with the vet’s recommendation, flare-ups and disease progression.
To register for the event, visit: https://tinyurl.com/43bm8mdx. All those who register will also be able to view a recording and enter a free prize draw for the chance to win tickets to attend London Vet Show live in November.
Based at UCLan’s Preston Campus, the new school will deliver foundation, undergraduate and postgraduate courses in areas such as veterinary medicine, bioveterinary science, veterinary clinical practice, veterinary physiotherapy and rehabilitation, and clinical animal behaviour and training.
Professor Graham Baldwin, UCLan Vice-Chancellor, said: “We’re absolutely delighted to be creating an innovative and dynamic veterinary school. UK veterinary schools are highly prestigious, so we are thrilled to be launching only the second school in the north of England and one of only 11 in the UK.
“We have taken massive strides in developing all areas of human health provision in recent years, and animal health will now join our ever-expanding portfolio of medicine, dentistry, pharmacy, biomedical sciences and optometry.”
Professor Cathy Jackson, Executive Dean of the Faculty of Clinical and Biomedical Sciences, said: “Our new veterinary school will be focussed on producing much needed industry ready graduates for our region, particularly as recent figures have highlighted a national shortage of vets and a sector heavily reliant on vets educated in the European Union.
"As with our medical and dental schools, we have demonstrated we want to break down barriers and make education accessible to all. It’s no different with our veterinary school and we want to open the doors and offer a pathway for any student, no matter of their background, into this rewarding profession, while maintaining the very highest of education and professional standards.”
The Batchelor of Veterinary Medicine and Surgery (BVMS) course at UCLan is a five-year programme with ‘hands-on’ modules from Year 1, rather than in the later years as delivered in more traditional programmes.
UCLan says it is collaborating with Myerscough College for some of its programmes to give students access to state-of-the-art, sector-leading facilities, which have recently benefited from a £35m investment.
In addition, UCLan will become one of the first universities in the world to make use of a digital, virtual dissection platform for teaching animal anatomy using veterinary Anatomage technology.
UCLan is planning to welcome the first intake of UK and international students to veterinary sciences BSc and foundation courses in September 2022 while BVMS students will be welcomed from 2023.
For more information, visit www.uclan.ac.uk/schools/veterinary-medicine.
The advice includes buying healthier breeds, not overfeeding, and reducing the amount of toys and accessories people buy for their pet.
BVA members can download other resources to help start conversations with clients, including a poster, which can be displayed in practice, and social media graphics.
British Veterinary Association Senior Vice President Dr Anna Judson said: “We know many vets are concerned about the role the veterinary profession has in protecting the planet, with our Voice of the Veterinary Profession statistics showing 68% of vets feel that vets are either very responsible or quite responsible for prioritising and leading on environmental issues.
"It’s also clear that many pet owners are becoming more interested in being more sustainable and the impact of their pets on the world.
"This new resource aims to support vets to have those conversations with clients and inspire them to become more sustainable pet owners, right from the moment of choosing what pet to welcome into their family.”
https://www.bva.co.uk/resources-support/client-guides/pet-sustainability
Containing 3% m/v Chlorhexidine, Pyoderm is designed to support the natural microbial balance of the skin whilst delivering gentle yet effective cleansing.
Along with the rest of Virbac's range of dermatological and everyday care shampoos, Pyoderm is presented in 250ml eco-friendly bottles which are made from 100% recycled plastic and recyclable packaging.
The shampoos themselves are also biodegradable.
https://uk.virbac.com/
The HT Vista device is used by vets and vet nurses to screen dermal and subcutaneous masses on dogs.
The company says that with a negative predictive value of 98% clinicians can confidently classify a mass as benign without the need of further invasive tests.
HT Vista also says that, according to a recent client survey, the main features which practices value are the nurse-led ability which is maximising nurse clinics and streamlining efficiency, justification in sampling masses even when they feel innocuous, and the rapid speed of image acquisition and results.
To be in with a chance of winning the device and subscription, delegates must attend the 15-minute Ultra Demo at stand B300 on Friday 22nd March at 4pm.
1,500 volunteers were surveyed for the study, which was led by Dr Francois Martin.
As well as having lower depression scores, dog owners were more likely to report feeling loved and valued during the pandemic than those who did not own a dog.
Owners also had a significantly more positive attitude toward and commitment to pets.
The full study is available open access here: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0260676
They include a webinar from In Communication, a company which specialises in veterinary client communications, which covers things like how to broach costs with clients, communicating treatment options succinctly and time-blind shared decision-making.
The Society has also published eight questions which the public may ask about the investigation, with model responses.
The resources also include a summary of the five concerns raised by the CMA, and advice about how to discuss them with practice staff.
Finally, you can download SPVS' presentation to the CMA which talks about the drivers for fee increases.
https://spvs.org.uk/cma-spvs-response
The event will include empowering talks by Vet Empowered founders Katie Ford and Claire Grigson MsRCVS.
Expert guests include Aoife Smith, an ex-RVN and psychotherapist, Chloé Hannigan from VetYogi and Jo Kelly, a registered veterinary nurse and accredited nutritional therapist.
There'll be hands-on workshops and immersive activities aimed at challenging comfort zones, fostering connections, and cultivating a mindset of growth and empowerment.
The organisers say Vet Empowered Live also offers the chance to connect with like-minded professionals, share experiences, and build a supportive community of peers committed to personal and professional growth.
Katie said: "We're thrilled to bring Vet Empowered Live to life and provide veterinary professionals with a unique opportunity to invest in their personal development.
"Our mission is to empower individuals to unlock their full potential, overcome obstacles, and create fulfilling careers on their own terms.
"We are passionate about providing a safe and inspiring space to do this."
Tickets cost £150 and include six hours of CPD and food and drink throughout the day.
https://www.eventbrite.co.uk/e/vet-empowered-live-confidence-beyond-manchester-2024-tickets-775605325407
https://www.vetempowered.com